Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    -0.11 (-8.40%)
Bid:
1.10
Ask:
1.30
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Device Authority Update

30 Sep 2024 07:00

RNS Number : 1267G
Tern PLC
30 September 2024
 

30 September 2024

Tern Plc

("Tern" or the "Company")

Device Authority Update

Tern Plc (AIM:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things ("IoT") technology businesses, announces an update in relation to Device Authority Limited ("Device Authority"), a company in which Tern has a 30.0% equity holding.

The remaining Tranche Two of the Device Authority Fundraising of US$3.3 million, by Ten Eleven Ventures ("Tranche Two") was, as announced on 27 December 2023, due to be completed on or prior to 30 September 2024. Due to the positive current performance of Device Authority, it has been agreed by the Device Authority board to defer the completion of Tranche Two to, if required, on or before 31 December 2024.

Tern's holding in Device Authority therefore remains unchanged at 30.0% (before any dilution on exercise of share options or the potential completion of Tranche Two), with this holding having an unaudited book valuation of approximately US$5.4 million (approximately £4.2 million), as announced on 9 August 2024.

Unless otherwise stated, defined terms should be given the meaning given to them in the Company's announcement made on 27 December 2023.

Further information on Device Authority

Device Authority is a global leader in Identity and Access Management ("IAM") for the IoT; focused on the automotive, medical device ("IoMT") and industrial ("IIoT") sectors. Device Authority's KeyScaler™ platform provides zero touch provisioning and complete automated lifecycle management for securing IoT devices and data at scale, with frictionless deployment across device provisioning, authentication, credential management, policy based end-to-end data security/encryption and secure OTA (over the air) and HSM (hardware security module) updates.

 

Enquiries

 

Tern Plc

Ian Ritchie (Chairman)

via IFC Advisory

 

Allenby Capital Limited

(Nominated Adviser and Broker)

Alex Brearley / Dan Dearden-Williams (Corporate Finance)

Kelly Gardiner / Guy McDougall (Sales and Corporate Broking)

 

Tel: 0203 328 5656

 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

Tel: 0203 934 6630

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUKRBRSUUKUAR
Date   Source Headline
10th Mar 20227:00 amRNSWyld Networks Purchase Orders
2nd Mar 20227:00 amRNSParticipation in SVV UK Software Technology Fund
22nd Feb 20223:09 pmRNSDevice Authority Agreement with Avnet
11th Feb 20227:00 amRNSPortfolio Update
1st Feb 20227:00 amRNSTalking Medicines Fund Raise
11th Jan 20221:45 pmRNSWyld Networks Connectivity Partnership
31st Dec 202112:30 pmRNSTotal Voting Rights
29th Dec 20214:41 pmRNSSecond Price Monitoring Extn
29th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Dec 202112:30 pmRNSChange in Wyld Networks Shareholding
20th Dec 20217:00 amRNSInVMA Fund Raise and Update
15th Dec 20213:04 pmRNSExercise of Options
13th Dec 20214:41 pmRNSSecond Price Monitoring Extn
13th Dec 20214:36 pmRNSPrice Monitoring Extension
13th Dec 20212:06 pmRNSSecond Price Monitoring Extn
13th Dec 20212:01 pmRNSPrice Monitoring Extension
8th Dec 20219:00 amRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
3rd Dec 20219:00 amRNSPrice Monitoring Extension
2nd Dec 20214:41 pmRNSSecond Price Monitoring Extn
2nd Dec 20214:35 pmRNSPrice Monitoring Extension
2nd Dec 20212:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20212:00 pmRNSPrice Monitoring Extension
2nd Dec 202110:01 amRNSDevice Authority Strategic Investment & Funding
1st Dec 20217:00 amRNSDevice Authority convertible loan notes
26th Oct 20217:00 amRNSPortfolio Update
20th Sep 20217:30 amRNSWyld purchase order from Bayer Crop Science
16th Sep 20217:00 amRNSInvestor webinar recording
14th Sep 20217:00 amRNSInterim Results
3rd Sep 20214:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20214:35 pmRNSPrice Monitoring Extension
3rd Sep 20212:05 pmRNSSecond Price Monitoring Extn
3rd Sep 20212:00 pmRNSPrice Monitoring Extension
3rd Sep 202111:05 amRNSSecond Price Monitoring Extn
3rd Sep 202111:00 amRNSPrice Monitoring Extension
25th Aug 20217:00 amRNSWyld Networks Third Party Funding
17th Aug 20217:00 amRNSInvestment in FundamentalVR and Portfolio Update
4th Aug 20214:41 pmRNSSecond Price Monitoring Extn
4th Aug 20214:35 pmRNSPrice Monitoring Extension
4th Aug 20212:06 pmRNSSecond Price Monitoring Extn
4th Aug 20212:00 pmRNSPrice Monitoring Extension
30th Jul 20215:18 pmRNSTotal Voting Rights
14th Jul 20217:00 amRNSResult of Fundraise
13th Jul 20215:07 pmRNSRetail Offer
13th Jul 20215:05 pmRNSEquity Fundraise of up to £4 million
2nd Jul 20218:05 amRNSWyld Networks - Trading on NASDAQ First North
28th Jun 202110:00 amRNSWyld Networks IPO Update
25th Jun 20214:40 pmRNSSecond Price Monitoring Extn
25th Jun 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.